Glucotrack, Inc. (GCTK) stock
GCTKOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.68−0.04 (-5.56%)
Close on Oct 19, 2026Market cap $3.43MP/E 0.0Yield –
Glucotrack operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Glucotrack's operating income for the twelve months ending Jun 30, 2026 was -$15.40M. For fiscal 2025 it was -$16.09M. The highest annual figure on record is $10.58M in fiscal 2017.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$16.09M | – |
| FY2024 | Dec 31, 2024 | -$14.55M | – |
| FY2023 | Dec 31, 2023 | -$7.10M | – |
| FY2022 | Dec 31, 2022 | -$4.43M | – |
| FY2021 | Dec 31, 2021 | -$4.04M | – |
| FY2020 | Dec 31, 2020 | -$3.13M | -189.3% |
| FY2019 | Dec 31, 2019 | $3.51M | – |
| FY2018 | Dec 31, 2018 | -$6.54M | -161.8% |
| FY2017 | Dec 31, 2017 | $10.58M | – |
| FY2016 | Dec 31, 2016 | -$5.66M | – |
| FY2015 | Dec 31, 2015 | -$4.66M | – |
| FY2014 | Dec 31, 2014 | -$3.61M | – |
| FY2013 | Dec 31, 2013 | -$3.03M | – |
| FY2012 | Dec 31, 2012 | -$2.77M | – |
| FY2011 | Dec 31, 2011 | -$2.33M | – |
| FY2010 | Dec 31, 2010 | -$1.39M | – |
| FY2009 | Dec 31, 2009 | -$1.17M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.40M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.20M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.49M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.31M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.80M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.50M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.85M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.25M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.49M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.95M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.42M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.22M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.18M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.28M | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.29M | – |
| Q3 FY2022 | Sep 30, 2022 | -$929.00K | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.12M | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.09M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.50M | – |
| Q3 FY2021 | Sep 30, 2021 | -$767.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -$873.00K | – |
| Q1 FY2021 | Mar 31, 2021 | -$896.00K | – |
| Q4 FY2020 | Dec 31, 2020 | -$878.00K | -113.7% |
| Q3 FY2020 | Sep 30, 2020 | -$887.00K | – |
| Q2 FY2020 | Jun 30, 2020 | -$611.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$756.00K | -173.8% |
| Q4 FY2019 | Dec 31, 2019 | $6.41M | – |
| Q3 FY2019 | Sep 30, 2019 | -$980.47K | – |
| Q2 FY2019 | Jun 30, 2019 | -$894.31K | – |
| Q1 FY2019 | Mar 31, 2019 | $1.03M | -46.3% |
| Q4 FY2018 | Dec 31, 2018 | -$1.01M | -105.5% |
| Q3 FY2018 | Sep 30, 2018 | -$1.61M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.01M | – |
| Q1 FY2018 | Mar 31, 2018 | $1.91M | -26.5% |
| Q4 FY2017 | Dec 31, 2017 | $18.47M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.65M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.65M | – |
| Q1 FY2017 | Mar 31, 2017 | $2.60M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.32M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.49M | – |
See a number that looks wrong?